Anja Sandek1, Alexander Swidsinski2, Wieland Schroedl3, Alastair Watson4, Miroslava Valentova5, Ralph Herrmann6, Nadja Scherbakov6, Larissa Cramer6, Mathias Rauchhaus6, Anke Grosse-Herrenthey3, Monika Krueger3, Stephan von Haehling6, Wolfram Doehner7, Stefan D Anker8, Juergen Bauditz9. 1. Division of Applied Cachexia Research, Department of Cardiology, Charité, Campus Virchow, Berlin, Germany; Department of Cardiology, Charité Medical School, Campus Virchow-Klinikum, Berlin, Germany. Electronic address: anja.sandek@charite.de. 2. Center for Stroke Research, Charité Medical School, Campus Virchow-Klinikum, Berlin, Germany. 3. Institute of Bacteriology and Mycology, Veterinary Faculty, Leipzig, Germany. 4. Norwich Medical School, University of East Anglia, Norwich Research Park, United Kingdom. 5. Division of Applied Cachexia Research, Department of Cardiology, Charité, Campus Virchow, Berlin, Germany; Department of Cardiology and Pulmonology, University Medical Centre Göttingen, Göttingen, Germany. 6. Division of Applied Cachexia Research, Department of Cardiology, Charité, Campus Virchow, Berlin, Germany. 7. Division of Applied Cachexia Research, Department of Cardiology, Charité, Campus Virchow, Berlin, Germany; Center for Stroke Research, Charité Medical School, Campus Virchow-Klinikum, Berlin, Germany. 8. Department of Innovative Clinical Trials, University Medical Centre Göttingen, Göttingen, Germany. 9. Department of Gastroenterology, Charité, Campus Mitte, Berlin, Germany.
Abstract
BACKGROUND: Blood flow in the intestinal arteries is reduced in patients with stable heart failure (HF) and relates to gastrointestinal (GI) symptoms and cardiac cachexia. OBJECTIVES: The aims of this study were to measure arterial intestinal blood flow and assess its role in juxtamucosal bacterial growth, GI symptoms, and cachexia in patients with HF. METHODS: A total of 65 patients and 25 controls were investigated. Twelve patients were cachectic. Intestinal blood flow and bowel wall thickness were measured using ultrasound. GI symptoms were documented. Bacteria in stool and juxtamucosal bacteria on biopsies taken during sigmoidoscopy were studied in a subgroup by fluorescence in situ hybridization. Serum lipopolysaccharide antibodies were measured. RESULTS: Patients showed 30% to 43% reduced mean systolic blood flow in the superior and inferior mesenteric arteries and celiac trunk (CT) compared with controls (p < 0.007 for all). Cachectic patients had the lowest blood flow (p < 0.002). Lower blood flow in the superior mesenteric artery and CT was correlated with HF severity (p < 0.04 for all). Patients had more feelings of repletion, flatulence, intestinal murmurs, and burping (p < 0.04). Burping and nausea or vomiting were most severe in patients with cachexia (p < 0.05). Patients with lower CT blood flow had more abdominal discomfort and immunoglobulin A-antilipopolysaccharide (r = 0.76, p < 0.02). Antilipopolysaccharide response was correlated with increased growth of juxtamucosal but not stool bacteria. Patients with intestinal murmurs had greater bowel wall thickness of the sigmoid and descending colon, suggestive of edema contributing to GI symptoms (p < 0.05). In multivariate regression analysis, lower blood flow in the superior mesenteric artery, CT (p < 0.04), and inferior mesenteric artery (p = 0.056) was correlated with the presence of cardiac cachexia. CONCLUSIONS: Intestinal blood flow is reduced in patients with HF. This may contribute to juxtamucosal bacterial growth and GI symptoms in patients with advanced HF complicated by cachexia.
BACKGROUND: Blood flow in the intestinal arteries is reduced in patients with stable heart failure (HF) and relates to gastrointestinal (GI) symptoms and cardiac cachexia. OBJECTIVES: The aims of this study were to measure arterial intestinal blood flow and assess its role in juxtamucosal bacterial growth, GI symptoms, and cachexia in patients with HF. METHODS: A total of 65 patients and 25 controls were investigated. Twelve patients were cachectic. Intestinal blood flow and bowel wall thickness were measured using ultrasound. GI symptoms were documented. Bacteria in stool and juxtamucosal bacteria on biopsies taken during sigmoidoscopy were studied in a subgroup by fluorescence in situ hybridization. Serum lipopolysaccharide antibodies were measured. RESULTS:Patients showed 30% to 43% reduced mean systolic blood flow in the superior and inferior mesenteric arteries and celiac trunk (CT) compared with controls (p < 0.007 for all). Cachectic patients had the lowest blood flow (p < 0.002). Lower blood flow in the superior mesenteric artery and CT was correlated with HF severity (p < 0.04 for all). Patients had more feelings of repletion, flatulence, intestinal murmurs, and burping (p < 0.04). Burping and nausea or vomiting were most severe in patients with cachexia (p < 0.05). Patients with lower CT blood flow had more abdominal discomfort and immunoglobulin A-antilipopolysaccharide (r = 0.76, p < 0.02). Antilipopolysaccharide response was correlated with increased growth of juxtamucosal but not stool bacteria. Patients with intestinal murmurs had greater bowel wall thickness of the sigmoid and descending colon, suggestive of edema contributing to GI symptoms (p < 0.05). In multivariate regression analysis, lower blood flow in the superior mesenteric artery, CT (p < 0.04), and inferior mesenteric artery (p = 0.056) was correlated with the presence of cardiac cachexia. CONCLUSIONS: Intestinal blood flow is reduced in patients with HF. This may contribute to juxtamucosal bacterial growth and GI symptoms in patients with advanced HF complicated by cachexia.
Authors: Sarah K Kirschner; Nicolaas E P Deutz; Renate Jonker; Steven W M Olde Damink; Rajesh I Harrykissoon; Anthony J Zachria; Srinivasan Dasarathy; Mariëlle P K J Engelen Journal: Clin Nutr Date: 2020-10-10 Impact factor: 7.324